RILYN Q1 2024 Earnings Significant Loss Reported Revenue Not Disclosed XOMAP Q1 2026 Earnings Preferred Stock Reports EPS Miss Amid Royalty Revenue Uncertainty MBX Biosciences Inc MBX Q1 2026 Earnings EPS Beat as PreRevenue Biotech Advances Pipeline GLDG Q1 2026 Earnings Narrowerthanexpected loss as exploration ramp continues TNGX Q1 2026 Earnings Largerthanexpected EPS miss amid prerevenue stage stock declines ARCB Q1 2026 Earnings EPS Surprise of 1536 Drives Stock Higher